Training & Education
Pharma MBAs — From Mini Courses to the Full Monty
Over the past decade there has been a marked increase in the variety of specialist pharma MBA courses on offer. These courses last from one week in the case of most mini MBAs, up to a year’s full-time study or equivalent. Accordingly, the depth of learning provided by these different types of course varies enormously, writes John Ansell...Read more
Regulatory
Pharma’s Social Media Struggles Continue
Pharma companies have been slow to take advantage of interactive social media, largely because of FDA rules that control what manufacturers can state about their products. The new guidances clarify some murky areas, but may not make online communications any easier, writes Jill Wechsler...Read more
The lifecycle of a new product is shorter, more contested, full of regulatory delays, and beset by a challenging access and reimbursement environment. Learn how to wrest maximum value from every stage of the lifecycle – from access to acquisition to adherence —  by downloading this eBook.
Technology
Apple or Big Pharma? Who Will Lead the Wearable Healthcare Technology Space?
Apple's iWatch may not have happened yet, but eyes are still fixed on the company to see what it does in the healthcare wearables space. And in this sector, the question might not be whether Apple can compete with Big Pharma, but whether Big Pharma will be able to play with Apple ...Read more
Special Feature
Pharm Exec’s Emerging Pharma Leaders 2014
From this year's class of 15 young leaders — Pharm Exec’s 8th annual Emerging Pharma Leaders survey — these five executives, selected from the areas of marketing innovation, product strategy and brand development, are leading the way in creating new opportunities and transforming raw data into "news I can use" analytics:
Jenise Doutsas, Global Strategic Lead, Fertility, Ferring ...Read more
Susanne Heinzinger, Executive Director of Product Strategy and Alliance Management, Achillion Pharmaceuticals ...Read more
Michael Injaychock, Director, Marketing Innovation, Research and Commercial Analytics, Eli Lilly & Co. ...Read more
Arnaud Lesegretain, Vice President, Global Brand Development, Eli Lilly & Co. ...Read more
Jocelyn Trokenheim, Head of Global Business Development Office and Strategy, Takeda Pharmaceuticals ...Read more |
